How to make your money go further

Tristel (AIM: TSTL) – brilliant results and all is looking good

25/02/2015 · Tristel (TSTL) 

The manufacturer of infection prevention, contamination control and hygiene products has announced terrific interim results for the six months ended 31 December 2014.

Revenue was up 15% to £7.4m including international sales up 26% to £2.4m, pre-tax profit before share based payments up 57% to £1.1m and basic EPS up 85% to 1.91p. 

The Group finished the period with net cash of £2.9m (2013: £1.5m)

Tristel’s lead technology is a proprietary Chlorine dioxide formulation addressing three distinct markets:

- The Human Healthcare market (hospital infection prevention - via the Tristel brand)
- The Contamination Control market (control of contamination in critical environments - via the Crystel brand)
- The Animal Healthcare market (veterinary practice infection prevention - via the Anistel brand)

The significant capital investment over the past few years, including £400,000 in creating 20,000 sq ft of new factory, office and warehouse space which was officially opened on 2nd October 2014 puts the business in great shape to support further growth. 

The Group’s proprietary technology that is supported by widespread patent protection covering two-thirds of…

Sign up and read the full article

Register to continue reading this article.

Get FREE access now

Already a member? Login

Have your say

Log in or register to view or add comments.

Investment news & insights

For access to the top news and insights from the investment world

REGISTER FREE TODAY

Investor's Champion Premium Content

Subscribers to our Premium Content receive priority notification by email of newly published research. Premium Content costs as little as £3.20 per research note.

More on Premium Content

More on Tristel

Investor’s Champion podcast: ISA time

03/04/2019 · Podcasts
It’s ISA time. With just two days to go before the ISA deadline, it’s a good…

Tristel gains key approval in China

01/04/2019 · Portfolio Flash News
Tristel has its sights firmly set on China as a crucial market for long-term revenue growth.…

Tristel looks to China for more growth

13/03/2019 · Portfolio
The value of Tristel’s medical device decontamination products are highlighted by the fact that the company…

6 quality AIM shares for your portfolio

15/10/2015 · Blog
Our Blog this week has featured results and updates from a number of wonderful small…

Tristel (AIM: TSTL) – cracking results and positive outlook bring out more upgrades

12/10/2015 · Blog
The AIM quoted manufacturer of infection prevention and contamination control products, announces excellent ‘audited’ results for…

More from the Blog

The Genius of Guinness

09/04/2019 · Diageo PLC

Tesla tanks on weaker than expected demand

04/04/2019 · Tesla

March 2019 AIM new arrivals - another poor month for newcomers and plenty of departures